ABBOTINDIA - IntraDay Trade Analysis with Live Signals

Last Updated Time : 05 Nov 25, 7:43 am

IntraDay Trade Rating: 3.2

📉 ABBOTINDIA shows strong fundamentals but weak technical momentum and low volume, making it a cautious intraday candidate.

📈 Positive

• 🔹 ROCE at 46.2% & ROE at 35.7%: Exceptional operational and equity efficiency.
• 🔹 EPS of ₹683: Indicates strong earnings power.
• 🔹 Low Debt-to-Equity: At 0.05, reflects a solid balance sheet.
• 🔹 Stable PAT: ₹366 Cr vs ₹367 Cr QoQ, showing consistent profitability.

⚠️ Limitation

• 🔸 MACD at -325: Strong bearish signal, indicating downward momentum.
• 🔸 RSI at 39.2: Below neutral, showing weak price strength.
• 🔸 Price Below 50 & 200 DMA: Current price (₹29,400) is under both DMAs, suggesting resistance overhead.
• 🔸 Low Volume: 8,723 vs 1Wk avg of 8,184 — thin liquidity for intraday moves.

🚫 Company Negative News

• 📉 Technical Breakdown: Price has slipped below key moving averages, triggering caution among traders.

✅ Company Positive News

• 💊 Product Expansion: Continued leadership in therapeutic segments like gastro, pain, and women’s health.
• 📊 Dividend Yield: At 1.62%, attractive for long-term investors.

🏦 Industry

• 🧪 Sector: Pharmaceuticals — Branded Formulations.
• 📊 Industry PE: 33.1, lower than ABBOTINDIA’s PE of 43.0, indicating premium valuation.

📌 Conclusion

• 📉 Intraday Setup: Weak MACD and RSI suggest limited upside; best suited for conservative trades.
• 💰 Optimal Buy Price: ₹29,200–₹29,300 (near recent support).
• 📈 Profit Exit Level: ₹29,600–₹29,700 (short-term resistance).
• 🛑 Stop Loss: ₹29,050 (below support zone).
• ⏳ If Holding: Exit if RSI dips below 38 or price fails to hold above ₹29,300 intraday.

I can chart ABBOTINDIA’s MACD and RSI zones to help you visualize ideal entry and exit timing.